Priority Review

Related by string. * priority . PRIORITY : OHL Priority Selection . Gmail Priority Inbox . Priority Senior Secured . Priority AF . Priority Inbox . Priority Healthcare . aperture priority / reviewing . reviewed . reviewer . Reviews . reviews . REVIEW : WEB HOST INDUSTRY REVIEW . peer reviewed journal . peer reviewed journals . Strategic Analysis Review . Spokesman Review . NOT REVIEWED AND DOES * *

Related by context. All words. (Click for frequent words.) 69 Fast Track Status 67 Fast Track Designation 67 FDA Orphan Drug 67 Orphan Drug designation 67 Orphan Designation 67 Orphan Drug Designation 67 Orphan Drug Status 66 Orphan Status 65 Orphan Drug status 64 Complete Response 64 orphan designation 64 Orphan Drug designations 63 Fast Track designation 63 orphan drug 63 Granted Orphan Drug 63 supplemental Biologics License Application 62 Act PDUFA date 62 orphan medicinal product 62 Accelerated Approval 61 Fast Track designations 61 FDA Accepts 61 Receives Fast Track 61 Orphan designation 61 Marketing Authorization Application 61 FDA Approvable Letter 61 Orphan Medicinal Product 60 PDUFA Date 60 Biological License Application 60 Biologics License Application 60 Biologics Licensing 60 Orphan Drug 60 Application BLA 60 Approvable Letter 60 Submits NDA 59 Expedited Review 59 MAA submission 59 BYETTA ® 59 Prescription Drug User Fee 59 OMP designation 59 Submits Supplemental 59 Supplemental Biologics License Application 59 Biologics License Application BLA 59 granted orphan 58 Expanded Indication 58 Receives Orphan Drug 58 Torisel 58 Biologic License Application 58 Pivotal Phase III 58 Psoriasis Drug 58 Marketing Authorisation Application 58 Grants Orphan Drug 58 approvable letters 58 Jevtana 58 Noxafil 58 Medicinal Products EMEA 58 Biologic License Application BLA 58 Receives Positive Opinion 58 Marketing Authorisation 58 Resubmission 58 European Medicines Evaluation 58 Marketing Authorization 58 BLA submission 57 highly purified pasteurized 57 Premarket Approval 57 granted Orphan Drug 57 Zenpep 57 Files IND 57 Generic Version Of 57 Cellegesic 57 Somatuline Depot 57 Submits Biologics License Application 57 Announces Tentative Approval 57 Cladribine Tablets 57 DORIBAX 57 Initiate Clinical Trial 57 CERVARIX R 57 PDUFA Prescription Drug 57 Receives Orphan Drug Designation 57 Tarceva TM 57 Act PDUFA 57 Civacir 57 GRAS notification 57 Zebinix R 57 Velaglucerase Alfa 57 Receives Tentative FDA 57 eprodisate Fibrillex TM 57 PROMACTA 57 Files Investigational 57 Approvable 57 submitted Biologics License 57 Investigational Compound 57 Voraxaze 56 Vandetanib 56 Arzerra ofatumumab 56 CLIA waiver 56 Febuxostat 56 ARIXTRA R 56 Phase III Clinical Trial 56 sNDAs 56 Mylan Receives Approval 56 Etanercept 56 BENLYSTA 56 Nabi HB Intravenous 56 CHMP recommendation 56 ixabepilone 56 RAPAFLO 56 Drug Submission 56 sBLA 56 Million Milestone Payment 56 Patent Broadly Covering 56 Alvesco R 56 Testosterone Gel 56 Impax ANDA 56 TORISEL 56 Biologics License Applications 56 NDA Submission 56 ZOLINZA 56 ZEGERID Chewable Tablets 56 RANK Ligand inhibitor 56 HCl capsules 56 GATTEX TM 56 Marketing Authorization Applications 56 daily Glumetza TM 56 systemic immunosuppressive drugs 55 NOXAFIL 55 Ustekinumab 55 STELARA TM 55 Sumatriptan Succinate 55 Initiates Phase III 55 Gamunex C 55 Risperidone Oral Solution 55 Pegloticase 55 Eltrombopag 55 novel oral anticoagulant 55 eltrombopag 55 Submits Investigational 55 PDUFA date 55 Receives Approvable Letter 55 Ciclesonide 55 Ganite ® 55 Levofloxacin 55 Archexin 55 Ranolazine 55 BRILINTA 55 granted orphan medicinal 55 pediatric exclusivity 55 SYCREST 55 Metformin GR 55 Iluvien ® 55 Application MAA 55 Emezine 55 ATryn R 55 Positive Opinion 55 Romiplostim 55 Advanced Melanoma 55 Phase IIb Clinical Trial 55 Synerx Pharma 55 TEMODAL 55 nanofiltered plasma derived 55 supplemental biologics 55 Patient Enrollment 55 oral cladribine 55 Ixempra 55 PDUFA 55 Marketing Authorization Application MAA 55 Icatibant 55 ONGLYZA ™ 55 Belimumab 55 Personalized Immunotherapy 55 Trobalt 55 Mepact 55 Conditional Approval 55 LUVENIQ 55 BENLYSTA ® 55 Kepivance 55 Liprotamase 55 Campath alemtuzumab 55 Xcytrin R 55 Ceflatonin ® 55 liver resection surgeries 55 acyclovir Lauriad R 55 alvimopan 55 Generic Versions 55 RAPTIVA 55 Rhucin ® 55 Milestone Payments 55 Tentative Approval 54 Hiberix 54 submitted Marketing Authorization 54 Arimoclomol 54 ARCOXIA 54 severe hypercholesterolemia 54 rilonacept 54 Oral BDP 54 Cutaneous T 54 tacrolimus capsules 54 Octreolin 54 IMiDs 54 rolling Biologics License 54 SBIR Grant 54 Patent Covering 54 sitaxsentan sodium 54 Cladribine tablets 54 treat GI GVHD 54 GTC recombinant human 54 Riluzole 54 dalbavancin 54 Fludara ® 54 Patient Enrolment 54 Oral Calcitonin 54 Anti TNF 54 Cethromycin 54 Barr ANDA 54 PROVENGE ® 54 ® decitabine 54 R sorafenib tablets 54 REBETOL combination therapy 54 XIAFLEX ™ 54 TroVax ® 54 ANDA Filing 54 Product Designation 54 WHO prequalification 54 severe gastroparesis 54 M Enoxaparin 54 Telavancin 54 GW# [003] 54 Cladribine 54 pseudobulbar affect PBA 54 Alemtuzumab 54 Esbriet ® 54 TNF Tumor Necrosis Factor 54 Somatuline R Autogel R 54 IND Application 54 SURFAXIN 54 Orphan Drugs 54 Topotecan 54 TORISEL TM 54 GRAS Status 54 MyVax R 54 Tezampanel 54 Pixantrone 54 FDA Approvals 54 briakinumab 54 Bezielle 54 BLA filing 54 Zorbtive TM 54 Bayer Onyx 54 HepaGam B 54 application sNDA 54 Loceryl ® 54 CLIA Waiver 54 Firazyr 54 Dalbavancin 54 ZEGERID Capsules 54 Proquin 54 TAXUS Element Stent System 54 Fabry Disease 54 Keppra ® XR 54 Raptiva ® 54 MAGE A3 ASCI 54 Oracea TM 54 sNDA 54 chronic idiopathic thrombocytopenic purpura 54 omacetaxine mepesuccinate 54 Accelerated Assessment 54 Tasigna nilotinib 54 Pirfenidone 54 Zytiga 54 Vitrasert R 54 Completes Patient Enrollment 54 ATryn ® 54 Bayer Nexavar 54 granted Orphan Designation 54 Aryplase 54 Drug Eluting Stent System 54 Salix Pharma 53 Preotact 53 Arranon 53 Fibrillex TM 53 TYGACIL 53 Darunavir 53 Generic Version 53 Launches Generic Version 53 Nebido 53 Dasatinib 53 Milestone Payment From 53 dosing intervals 53 sorafenib tablets 53 UCB Cimzia 53 CIP TRAMADOL ER 53 Adjuvant Treatment 53 Schizophrenia Drug 53 Phase 2b Clinical Trial 53 OLEPTRO 53 Receives Complete Response 53 IND Filing 53 adalimumab Humira 53 VIVITROL ® 53 Onco TCS 53 Pivotal Phase 53 Rheumatoid Arthritis Drug 53 Lupus Drug 53 Desvenlafaxine 53 Meets Primary Endpoint 53 GRALISE 53 Initiates Clinical Trial 53 CryoSeal FS System 53 Marketing Authorisation Application MAA 53 FDA Clearance 53 granted Fast Track 53 Sanvar R 53 Nexavar sorafenib tablets 53 Prostate Cancer Vaccine 53 OMAPRO ™ 53 GTC recombinant form 53 proprietary transdermal patch 53 Therapeutic Discovery Project 53 etravirine 53 Efficacy Results 53 Evoltra ® 53 ezogabine 53 Nexavar ® 53 FDA approvable letter 53 Inhaled Insulin 53 Demonstrates Significant 53 Dabigatran etexilate 53 octreotide acetate 53 Pfizer Sutent 53 Pivotal Trial 53 Sanctura XR 53 Benazepril 53 Clolar 53 k Clearance 53 Lubiprostone 53 tiapamil 53 Bronchitol 53 Natroba 53 FDA Complete Response 53 Blood Pressure Drug 53 Eraxis 53 Ganciclovir 53 HP Acthar Gel repository 53 Entereg alvimopan 53 Dapagliflozin 53 rosuvastatin calcium 53 FDA Modernization Act 53 Clevudine 53 Iloperidone 53 interferon gamma 1b 53 include Alferon N 53 Golimumab 53 VISICOL R 53 Fixed Dose Combination 53 Maribavir 53 Investigational Device Exemption 53 indiplon capsules 53 Solzira TM 53 IRESSA 53 Gout Drug 53 DexaSite 53 Soliris TM eculizumab 53 Sprycel dasatinib 53 Glatiramer Acetate 53 Piperacillin 53 Luveniq 53 pediatric Crohn disease 53 Metformin HCl 53 oral ridaforolimus 53 Cefprozil 53 SPRYCEL ® 53 Prodarsan R 53 Bafetinib 53 FROVA 53 subsidiaries visit http:/www.apricusbio.com 53 Generic Protonix 53 Dacogen injection 53 ELIQUIS 53 Octreotide 53 markets HP Acthar 53 Methylnaltrexone 53 Pafuramidine 53 Etravirine 53 nasal calcitonin product 53 Raptiva R 53 Targretin capsules 52 Taro Receives 52 IND Investigational New 52 ABILIFY ® 52 Acetavance TM 52 azacitidine 52 Advagraf 52 Pruvel 52 Troxatyl 52 YERVOY 52 Anidulafungin 52 desvenlafaxine 52 Azathioprine 52 Promacta 52 Alitretinoin 52 MEZAVANT 52 Abiraterone acetate 52 Orathecin 52 Zalbin 52 refractory chronic lymphocytic 52 GVAX cancer 52 PDE4 inhibitor 52 ENTEREG ® 52 Tekamlo 52 ENLIGHT 52 Orapred ODT 52 Campath ® 52 Premarket Approval Application 52 Evoltra 52 Roche Actemra 52 Mutual Recognition Procedure 52 FOLOTYN ® 52 registrational studies 52 ZALBIN 52 PREOS R 52 Clofarabine 52 USFDA approval 52 Dyloject TM 52 Linjeta TM 52 successfully commercialize Iluvien 52 Flovent HFA 52 Safe GRAS status 52 BiovaxID TM 52 REVLIMID R 52 NUVIGIL 52 Investigational Treatment 52 Kuvan 52 Phase IIb Trial 52 Emend 52 velaglucerase alfa 52 EMEND 52 temsirolimus 52 Pivotal Study 52 granted Ortec 52 Investigational Drug 52 cinacalcet HCl 52 ONGLYZA TM 52 Receives CE Marking 52 Somatuline Autogel 52 gastrointestinal disorders characterized 52 Paragraph IV 52 Release Capsules 52 Gleevec Glivec 52 Pralatrexate 52 submitted supplemental Biologics 52 Marqibo 52 mertansine 52 TELINTRA 52 hoFH 52 VALSTAR 52 Protease Inhibitor 52 Prodarsan 52 ORENCIA R 52 DIFICID ™ 52 Argatroban 52 pancreatic enzyme replacement 52 Drug Fails 52 Tramadol ER 52 RELISTOR ® 52 Preotact R 52 Advexin 52 Saforis 52 corticotropin injection 52 Cimzia ® 52 SUPPRELIN R LA 52 assigned PDUFA 52 BLP# Liposome Vaccine 52 post menopausal osteoporosis 52 ADVEXIN 52 Pazopanib 52 Panzem R 52 pregabalin Lyrica 52 Vidaza azacitidine 52 Extended Release Tablets 52 Methylphenidate Transdermal System 52 REMOXY NDA 52 R lenalidomide 52 LIALDA 52 AdreView 52 targeted radiotherapeutic 52 SinuNase TM 52 HCV Protease Inhibitor 52 histamine dihydrochloride 52 Vilazodone 52 Zenvia ™ 52 Tesamorelin 52 submit Biologics License 52 Epilepsy Drug 52 Teva Provides Update 52 Oracea R 52 investigational pharmacologically unique 52 ELAPRASE 52 Cimzia TM 52 Panzem R NCD 52 Fortical R 52 selective A2A adenosine receptor 52 FDA Approval 52 THALOMID 52 Velcade bortezomib 52 FTY# 52 Bevacizumab 52 Mipomersen 52 Orphan medicinal 52 miconazole Lauriad R 52 SEASONALE R 52 PrevOnco ™ 52 VPRIV 52 Stavzor 52 QNEXA 52 albinterferon alfa 2b 52 Keppra ® levetiracetam 52 topical gel formulation 52 StaphVAX R 52 JANUVIA 52 Angiox ® 52 formerly LymphoStat B 52 Elagolix 52 Peginterferon alfa 2b 52 R Saizen R 52 Laquinimod 52 Treatment IND 52 CERVARIX 52 Ultracet R 52 Certican 52 Qualifying Therapeutic Discovery 52 Neurodex 52 INC# 51 TYZEKA 51 Fluviral 51 Levoleucovorin 51 Aloxi Injection 51 Amrubicin 51 Oracea ® 51 BEMA Granisetron 51 Aflibercept 51 methylnaltrexone bromide 51 Silenor ® doxepin 51 Evoltra R 51 PRISTIQ 51 Soriatane 51 ACOMPLIA R 51 y Ambiente SERNA Honduras 51 Horizant ™ 51 Zarnestra 51 Phase 2a Trial 51 ONCASPAR 51 Anturol TM 51 Arcalyst 51 AERIUS 51 Inhalation Aerosol 51 miconazole Lauriad 51 MethyPatch 51 ustekinumab 51 Zirgan 51 APF# 51 mesylate tablets approved 51 Rebif ® 51 Glucophage XR 51 Xolegel 51 Fodosine 51 Troxatyl TM 51 SEROQUEL XR 51 Synvisc ONE 51 Bendamustine 51 OTC ZEGERID 51 hypereosinophilic syndrome 51 Provenge prostate cancer 51 Neuromodulation System 51 GLP1 agonist 51 SNT MC# 51 Evoltra TM 51 vemurafenib 51 RSR# 51 prGCD 51 Delayed Release 51 #k Clearance 51 AVASTIN 51 cutaneous T 51 guanfacine extended release 51 pemetrexed Alimta 51 Loxapine 51 UPLYSO 51 injectable formulations 51 Thalidomide Pharmion 51 Demonstrates Potential 51 Centralized Procedure 51 UCB Keppra 51 REVLIMID lenalidomide 51 pancreatic insufficiency 51 receptor tyrosine kinase inhibitor 51 AstraZeneca Symbicort 51 Ceflatonin 51 balsalazide tablet 51 Reclast Aclasta 51 vilazodone 51 albiglutide 51 Kuvan R 51 CONBRIZA 51 Loramyc R 51 SILENOR 51 herpetic keratitis 51 Gleevec imatinib mesylate 51 Surfaxin LS 51 PROVIGIL 51 Zolpimist 51 Genasense ® 51 Zegerid OTC 51 autologous cellular immunotherapy 51 Amlodipine Besylate Tablets 51 PGL# 51 Tygacil 51 Extended Release 51 Diabetic Macular Edema 51 Alair System 51 Initiate Phase 51 bevacizumab Avastin 51 Toctino R 51 Lamictal ODT 51 Ganite R 51 Phase 2b Trial 51 novel emulsion formulation 51 abatacept Orencia 51 Exalgo TM 51 vandetanib 51 BEXXAR 51 dasatinib Sprycel ® 51 BioDelivery Sciences 51 Bazedoxifene 51 ALN PCS 51 Chemical Entity NCE 51 Sycrest 51 Topiramate Tablets 51 FUSILEV ® 51 Submits Response 51 Plicera 51 Phenoptin 51 Approvable letter 51 Subpart E 51 ALVESCO R 51 NMEs 51 Ophthalmic Drugs Advisory 51 generation purine nucleoside 51 Accelerating apoptosis may 51 5 lipoxygenase inhibitor 51 investigational humanized monoclonal antibody 51 oxymorphone ER 51 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 51 Medoxomil 51 Frova ® 51 Lamivudine 51 topical NSAID 51 peginesatide 51 Cinacalcet HCl 51 BioDelivery 51 Sodium oxybate 51 Xyrem ® 51 zolpidem tartrate sublingual tablet 51 vernakalant hydrochloride 51 alefacept 51 Daclizumab 51 Granulocyte Colony Stimulating Factor 51 cladribine 51 SEASONIQUE 51 Actemra tocilizumab 51 ZEVALIN ® 51 CAELYX 51 MabCampath 51 Dupuytren Contracture 51 Mimpara 51 Montelukast 51 LibiGel ® 51 efalizumab 51 include Phenoptin TM 51 Sebivo 51 Metastatic Colorectal Cancer 51 Complete Response Letter 51 Loramyc ™ 51 Sutent sunitinib 51 Silodosin 51 lintuzumab SGN 51 DPX Survivac 51 T Pred 51 FDA Okays 51 Wyeth Torisel 51 Intermezzo ® NDA 51 IgG1 monoclonal antibody 51 k Premarket Notification 51 Syndrome LEMS 51 authority Gurian Sherman 51 taliglucerase alfa 51 lorcaserin NDA 51 delivers fluocinolone acetonide FA 51 Lilly Cymbalta 51 Oxaliplatin Injection 51 NEBIDO 51 ATPace TM 51 Exocrine Pancreatic Insufficiency 51 Terbinafine 51 Taxotere ® 51 Rasagiline 51 oral iron chelator 51 Ramelteon 51 drug ISA# 51 Gel repository corticotropin injection 51 OMNARIS HFA 51 CCR5 antagonist 51 iloperidone 51 Fanapt ™ 51 tafamidis 51 METOZOLV ODT 51 Fluconazole 51 YONDELIS 51 Durezol TM 51 investigational therapies 51 Increlex ® 51 ANTEGREN 51 Clolar ® 51 Esbriet pirfenidone 51 ISENTRESS raltegravir 51 Regeneron Pharma 51 Research CDER 51 Tamsulosin capsules 51 L BLP# 51 Pentacel vaccine 51 Phase III Trial 51 Increlex TM 51 Trelstar R 51 tasocitinib 51 Vpriv 51 GARDASIL ® 51 Rilonacept 50 Zolinza 50 Soliris eculizumab 50 Subpart H 50 ZACTIMA 50 vinorelbine emulsion 50 Teflaro 50 Oral Suspension 50 VIDAZA 50 Dexilant 50 novel bactericidal 50 Kit CD# positive 50 ankylosing spondylitis psoriatic arthritis 50 Ranexa R 50 Pliaglis 50 phase IIb trial 50 Pivotal Clinical Trial 50 Recommends Approval 50 sublingual tablets 50 thymalfasin 50 visit http:/www.mannkindcorp.com 50 Mozobil 50 OMAPRO 50 Angiox 50 IV acetaminophen 50 XGEVA 50 anidulafungin 50 LymphoStat B belimumab 50 Cefprozil tablets 50 torezolid phosphate 50 oral methylnaltrexone 50 Ampligen 50 JOULFERON 50 COLAZAL R 50 R adalimumab 50 sunitinib malate 50 ADVEXIN p# therapy 50 Q#IR 50 Eligard R 50 Ambrisentan 50 Optimer Pharma 50 Shows Statistically Significant 50 Generx TM 50 approvable letter 50 Hycamtin 50 SEBIVO 50 FDA Approves Expanded 50 thalidomide Thalomid 50 cycle oral contraceptive 50 Tostrex 50 Ilaris 50 Stelara 50 oxaliplatin Eloxatin 50 Taclonex R 50 Genzyme Myozyme 50 Allovectin 7 50 Polyphenon ® E 50 onabotulinumtoxinA 50 Hedgehog Pathway Inhibitor 50 etanercept Enbrel 50 dirucotide MBP# 50 COLAZAL 50 Traficet EN 50 Talabostat 50 dextromethorphan quinidine 50 CHMP opinion 50 ACUROX ® 50 Omigard TM 50 VIAject R 50 exenatide injection 50 Cervical Cancer Vaccine 50 balsalazide 50 ANDAs 50 Zidovudine Tablets 50 Complete Response letter 50 Phase III Clinical Trials 50 sapropterin dihydrochloride 50 Secretaria de Recursos Naturales 50 Tablets #mg [002] 50 investigational monoclonal antibody 50 proteasome inhibitor 50 Stedesa 50 DYSPORT 50 Sunesis Pharma 50 Oral Spray 50 tocilizumab 50 oral rivaroxaban 50 Mg Uk 50 Filgrastim 50 Namenda XR 50 EvaMist TM 50 Altabax 50 Aztreonam Lysine 50 Premarket Approval PMA 50 PROMACTA ® 50 ibuprofen Injection 50 Onsolis 50 CCHIT Certification 50 Ticagrelor 50 GlaxoSmithKline Tykerb 50 solifenacin succinate 50 Increlex R 50 Focalin XR 50 REMINYL ® 50 Aloxi ® 50 paliperidone palmitate 50 Receives Marketing Authorization 50 ATryn 50 Rhucin R 50 investigational atypical antipsychotic 50 mg Tablets 50 5mg #mg #mg 50 Nexavar sorafenib 50 Bupropion HCl ER 50 PLK1 SNALP 50 Fondaparinux 50 Corlux 50 heterozygous FH 50 NEBIDO R 50 Panzem 50 Eszopiclone 50 ATryn ® GTC recombinant 50 Vertex hepatitis C 50 Proquin XR 50 ImClone Erbitux 50 Arzerra TM 50 vitreoretinal disorders 50 GEM #S 50 R vancomycin hydrochloride 50 Final Approval 50 Uplyso 50 POSIDUR TM 50 Treanda 50 Humira adalimumab 50 Kombiglyze XR 50 Omapro 50 forodesine 50 Tamsulosin 50 daptomycin 50 Calcium Acetate 50 Safe GRAS 50 Eliquis 50 ALN TTR 50 ACZ# 50 Initiates Phase II 50 PentaStaph 50 Hatch Waxman exclusivity 50 Mycograb 50 Votrient 50 lucinactant 50 pralatrexate injection folate analogue 50 Zingo TM 50 DRUG ADMINISTRATION 50 Anturol ® 50 faropenem 50 SinuNase ™ 50 Tasimelteon 50 Recombinant Human 50 Prestara 50 OMNARIS Nasal Spray 50 LEUKINE 50 R bendamustine hydrochloride 50 TRANSDUR Sufentanil 50 QVAR 50 OTC Zegerid 50 Improves Outcomes 50 registrational trial 50 Onconase 50 oral prodrug 50 enoxaparin sodium injection 50 Simulect 50 Glybera R 50 designated Restanza 50 clofarabine 50 PNP inhibitor 50 Exalgo 50 Kynapid 50 Degarelix 50 FACTIVE R gemifloxacin 50 5 HT3 antagonist 50 miconazole Lauriad ® 50 metformin HCl 50 Shingles Vaccine 50 ambrisentan 50 GENERIC SILDENAFIL SOFT Generic 50 Xyzal R 50 topical ophthalmic 50 Extended Release Capsules 50 Gralise 50 Combo Therapy 50 Epratuzumab 50 Combidex 50 diarrhea predominant irritable 50 Carfilzomib 50 ACUROX 50 fluvoxamine maleate 50 NetLogic Microsystems Reports Inducement 50 Seasonal Influenza Vaccine 50 miconazole MBT 50 Aclasta Reclast 50 Vidaza 50 Tyverb 50 ZEFTERA TM Zevtera TM 50 Velac 50 ANDA submission 50 Voluntary Withdrawal 50 HoFH 50 Torisel temsirolimus 50 Cethrin 50 Relistor 50 KIACTA ™ 50 orBec 50 PROGENSA R 50 Tofacitinib 50 Ciclopirox 50 NTIOL 50 Allovectin 7 R 50 Renvela ® 50 Lambert Eaton Myasthenic 50 Drug Approvals 50 Peramivir 50 AZILECT R 50 Improves Survival 50 rasagiline tablets 50 Darbepoetin Alfa 50 Horizant 50 subcutaneously administered 50 novel histone deacetylase 50 Tibotec Therapeutics division 50 New Drug Application 50 erlotinib Tarceva ® 50 Saxagliptin 50 adult chronic ITP 49 human C1 inhibitor 49 Receives Tentative Approval 49 Zavesca R 49 Drug Submission NDS 49 VIBATIV 49 Aloxi R 49 Pfizer maraviroc 49 Azacitidine 49 Azedra 49 DOR BioPharma Announces 49 Fenofibrate 49 ORENCIA ® 49 IMiDs ® compound 49 Herceptin trastuzumab 49 AstraZeneca Iressa 49 panitumumab Vectibix 49 Adcirca 49 Rifaximin 49 Roflumilast 49 Fingolimod 49 markets COLAZAL 49 investigational hepatitis B 49 orally administered inhibitor 49 Flutiform ™ 49 lasofoxifene 49 Toctino ® 49 nephropathic cystinosis cystinosis 49 naproxen esomeprazole magnesium 49 Pravastatin 49 Complicated Skin 49 Thalidomide Pharmion #mg 49 IL# PE#QQR

Back to home page